IS6532A - Lyfjaform til stýrðrar losunar á síprófloxasíni með inntöku um munn einu sinni á dag - Google Patents

Lyfjaform til stýrðrar losunar á síprófloxasíni með inntöku um munn einu sinni á dag

Info

Publication number
IS6532A
IS6532A IS6532A IS6532A IS6532A IS 6532 A IS6532 A IS 6532A IS 6532 A IS6532 A IS 6532A IS 6532 A IS6532 A IS 6532A IS 6532 A IS6532 A IS 6532A
Authority
IS
Iceland
Prior art keywords
ziprofloxacin
oral administration
once daily
dosage formulation
dosage
Prior art date
Application number
IS6532A
Other languages
English (en)
Icelandic (is)
Inventor
Talwar Naresh
N. Staniforth John
Rampal Ashok
Mukherji Gour
N. Vishwanathan Badri
Khera Brij
Original Assignee
Ranbaxy Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited
Publication of IS6532A publication Critical patent/IS6532A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS6532A 2000-03-03 2002-08-28 Lyfjaform til stýrðrar losunar á síprófloxasíni með inntöku um munn einu sinni á dag IS6532A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51788700A 2000-03-03 2000-03-03
PCT/IB2001/000279 WO2001064183A1 (en) 2000-03-03 2001-02-28 Orally administered controlled delivery system for once daily administration of ciprofloxacin

Publications (1)

Publication Number Publication Date
IS6532A true IS6532A (is) 2002-08-28

Family

ID=24061635

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6532A IS6532A (is) 2000-03-03 2002-08-28 Lyfjaform til stýrðrar losunar á síprófloxasíni með inntöku um munn einu sinni á dag

Country Status (31)

Country Link
EP (1) EP1263409A1 (es)
JP (1) JP2003525229A (es)
KR (1) KR20030009374A (es)
CN (1) CN1420763A (es)
AP (2) AP1485A (es)
AR (1) AR032614A1 (es)
AU (1) AU3589701A (es)
BG (1) BG107055A (es)
BR (1) BR0108958A (es)
CA (1) CA2400950A1 (es)
CZ (1) CZ20022883A3 (es)
DO (1) DOP2001000130A (es)
EA (1) EA200200914A1 (es)
EC (1) ECSP013952A (es)
EE (1) EE200200497A (es)
GT (1) GT200100033A (es)
HN (1) HN2001000038A (es)
HR (1) HRP20020715A2 (es)
HU (1) HUP0204417A3 (es)
IL (1) IL151553A0 (es)
IS (1) IS6532A (es)
MX (1) MXPA02008568A (es)
NO (1) NO20024108L (es)
NZ (1) NZ520927A (es)
OA (1) OA12381A (es)
PE (1) PE20011113A1 (es)
PL (1) PL365071A1 (es)
SK (1) SK12542002A3 (es)
WO (1) WO2001064183A1 (es)
YU (1) YU66202A (es)
ZA (1) ZA200206764B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
US20030229101A1 (en) * 2002-06-06 2003-12-11 Sherman Bernard Charles Tablets comprising ciprofloxacin hydrochloride
DE10351448A1 (de) 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
DE602005007205D1 (de) * 2005-07-19 2008-07-10 Ethypharm Sa Gastroretentive Zusammensetzungen und Verfahren zur Herstellung
EP1880722B1 (en) * 2006-07-19 2010-03-17 Tabuk Pharmaceutical Manufacturing Co. Pharmaceutical compositions of ciprofloxacin
US10363288B2 (en) 2015-01-14 2019-07-30 National Jewish Health Insulin mimotopes and methods of using the same
WO2017143438A1 (en) * 2016-02-23 2017-08-31 Matripharm International Inc. Dual-rate release formulation with high drug loading
AU2017236977B2 (en) 2016-03-24 2022-05-26 Immunomolecular Therapeutics, Inc. Methods of treating autoimmune disease
US11052060B2 (en) 2018-02-12 2021-07-06 The Regents Of The University Of Colorado, A Body Corporate Compounds and methods for treating autoimmunity
US11013707B2 (en) 2018-03-23 2021-05-25 The Regents Of The University Of Colorado, A Body Corporate Administration of oral methyldopa
CN109806237A (zh) * 2019-03-13 2019-05-28 悦康药业集团上海制药有限公司 一种乳酸环丙沙星泡腾片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
JPH0624959A (ja) * 1991-10-04 1994-02-01 Bayer Yakuhin Kk 胃内浮遊型薬物徐放性固形製剤
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
DE19839057A1 (de) * 1998-08-28 2000-03-02 Koch Berthold Spülluft-Regler für eine Trockenvorrichtung für Druckluft
EE200100153A (et) * 1998-09-14 2002-06-17 Ranbaxy Laboratories Limited Kontrollitav ravimiväljutussüsteem ravimite suukaudseks manustamiseks, mis pakub ajalist ja ruumilist kontrolli

Also Published As

Publication number Publication date
EP1263409A1 (en) 2002-12-11
PL365071A1 (en) 2004-12-27
YU66202A (sh) 2005-09-19
KR20030009374A (ko) 2003-01-29
NO20024108L (no) 2002-10-25
ZA200206764B (en) 2003-03-04
BR0108958A (pt) 2003-09-30
GT200100033A (es) 2001-10-25
HUP0204417A2 (en) 2003-05-28
CA2400950A1 (en) 2001-09-07
JP2003525229A (ja) 2003-08-26
ECSP013952A (es) 2002-04-23
HUP0204417A3 (en) 2005-03-29
CZ20022883A3 (cs) 2003-04-16
CN1420763A (zh) 2003-05-28
AP1485A (en) 2005-10-31
AP2002002627A0 (en) 2002-09-30
BG107055A (bg) 2003-06-30
AP2001002084A0 (en) 2001-03-31
MXPA02008568A (es) 2003-02-24
HN2001000038A (es) 2005-03-23
IL151553A0 (en) 2003-04-10
OA12381A (en) 2004-09-06
AR032614A1 (es) 2003-11-19
PE20011113A1 (es) 2001-10-14
NO20024108D0 (no) 2002-08-28
SK12542002A3 (sk) 2003-05-02
HRP20020715A2 (en) 2004-12-31
DOP2001000130A (es) 2004-03-31
NZ520927A (en) 2003-06-30
EA200200914A1 (ru) 2003-02-27
WO2001064183A1 (en) 2001-09-07
EE200200497A (et) 2004-02-16
AU3589701A (en) 2001-09-12

Similar Documents

Publication Publication Date Title
IS6892A (is) Lyfjasamsetningar, skammtaform og aðferðir til aðgefa epóþílon um munn
PL356358A1 (en) Solid dosage form of someticone for oral administration
EG23943A (en) Flash-melt oral dosage formulation
NO20020208D0 (no) Flytende sammensetninger for oral administrasjon
DK1158992T3 (da) Anvendelse af xenon til fremstilling af et farmaceutisk præparat til behandling af neurointoksikationer
NO20020976D0 (no) Retarderte, orale, farmasöytiske administreringsformer
HUP0302319A3 (en) Pharmaceutical composition for oral administration of active ingredient
IS6994A (is) Arípíprazóllausn til gjafar um munn
IS4360A (is) Lyfjablanda í skammtaformi til munninntöku
NO20034862L (no) Formulering med oksykodon for administrering en gang pr dag
IS2184B (is) Lyfjaform með áfangalosun til inntöku um munn
IL166489A (en) Oral dosage form in single-dose administration containing at least two layers for the administration and use of flipridone
NO20022058D0 (no) Farmasöytiske sammensetninger
EE200000383A (et) Peroraalne farmatseutiline pikendatud vabanemisega annusvorm
IS6532A (is) Lyfjaform til stýrðrar losunar á síprófloxasíni með inntöku um munn einu sinni á dag
DK1334717T3 (da) Farmaceutiske sammensætninger til oral og topisk administrering
NO20014738L (no) Tolperisonholdig farmasöytisk preparat for oral administrering
HUP0500638A3 (en) Flashmelt oral dosage formulation
FI20000780A (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
NO20021898D0 (no) Farmasöytisk sammensetning inneholdende ciclesonid for applikasjon til mukosa
NO20040047L (no) Farmasoytisk formulering for intramuskulaer administrering av fulvestrant
NO20025394D0 (no) Formuleringer inneholdende et glukokorticoid legemiddel for behandling av bronkopulmonire sykdommer
HUP0300402A3 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them
NO20003799L (no) Innkorporering av kolesterol senkende midler i konfekt- dosisformer
NO20032581D0 (no) Farmasöytisk formulering av gepiron for oral administrering